BIO announces CEOs of Codexis, Gevo to speak on advanced biofuels at Pacific Rim Summit in November

In Hawaii, the 2009 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will be held Nov. 8-11, 2009 in Honolulu. Speakers for the plenary session on Advanced Biofuels: Status of Commercialization Efforts include: Pat Gruber, CEO of Gevo, Alan Shaw, CEO of Codexis, and Joel Velasco, Chief Representative, North America, UNICA. The full schedule for the conference is available here.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Poet, Novozymes, Aventine, Ceres CEOs to speak in Chicago, New York

The CEOs of Poet, Ceres, Novozymes and Aventine Renewable Energy will be headlining separate conferences this month in Chicago and New York. Poet CEO Jeff Broin, Novozymes CEO Steen Riisgaard and Cere...

CHI issues call for papers at Second Advanced Biofuels Development Summit

CHI has issued an initial call for papers for the 2nd Advanced Biofuels Development Summit, scheduled from April 20-21, 2009 at the Marriott at Metro Center in Washington, DC.  Biofuels Digest is ...

Dyadic receives last installment in $10 million payment from Codexis for enzyme production system

In Florida, Dyadic filed an SEC 8-K form confirming that the company has received the final installment in $10 million in upfront payments from Codexis for a license to utilize "the use of Dyadic's C1...

Shell Oil to expand investment in Codexis, adds one more board seat; Codexis to further optimize Shell-Iogen cellulosic ethanol biocatalysts

In California, Codexis announced that it has received an increased investment from Shell to accelerate its development timetable for commercial biofuels. The company said that Shell will also take an ...

Shell purchases stake in Codexis, an enzyme manufacturer for cellulosic ethanol

Shell has purchased an undisclosed stake in stake in Codexis, a company which manufactures enzymes for the cellulosic ethanol production process. Codexis executives said that they expect to build a co...

Codexis licenses biomanufacturing technology for $10 million, to improve enzyme production cycle time

In Florida, Dyadic International announced that it has licensed its biomanufacturing technology to Codexis for $10 million. Codexis said that it would use the technology in conjunction with its synthe...